drugset / Trial / NCT00842114
Rituximab and CVP Plus Interferon for Follicular Non Hodgkins Lymphoma (NHL)
NaSingle-groupOpen-labelTreatment
Summary
Rituximab plus CVP and Interferon chemoimmunotherapy for newly diagnosed Follicular Lymphoma with FLIPI index \>2
Timeline
- Start
- 2006-02
- Primary completion
- 2016-03
- Completion
- 2016-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclophosphamide | Other / unclassified | 400 mg/m2 | — |
| Subject | Prednisone | Other / unclassified | 100 mg/m2 | — |
| Subject | Rituximab | Monoclonal antibody | 375 mg/m2 | — |
| Subject | Vincristine | Small molecule | 1.4 mg/m2 | — |
| Subject | interferon alfa-2b | Protein / enzyme biologic | 3 unknown | — |